Clover Health Investments, Corp. (CLOV)
NASDAQ · Healthcare
Clover Health Investments, Corp. EBITDA 2019–2025
Clover Health Investments, Corp. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Clover Health Investments, Corp. ebitda for the quarter ending March 31, 2026 was 26.9 M, a 1671.77% decrease year-over-year.
- Clover Health Investments, Corp. ebitda for the twelve months ending March 31, 2026 was -9.0 M, a 84.39% decrease year-over-year.
- Clover Health Investments, Corp. annual ebitda for 2025 was -87.4 M, a 81.00% increase from 2024.
- Clover Health Investments, Corp. annual ebitda for 2024 was -48.3 M, a 76.94% decrease from 2023.
- Clover Health Investments, Corp. annual ebitda for 2023 was -209.3 M, a 27.35% decrease from 2022.
- Clover Health Investments, Corp. annual ebitda for 2022 was -288.2 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Clover Health Investments, Corp. EBITDA — FAQ
Clover Health Investments, Corp. (CLOV) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLOV's ebitda history?
The chart and table above show Clover Health Investments, Corp.'s ebitda by year and by quarter, including the growth rate.